Monographs: Pharmaceutical substances: Estradiol cipionate (Estradioli cipionas)

Molecular formula. C26H36O3

Relative molecular mass. 396.56

Graphic formula

Chemical name. 3-hydroxyestra-1,3,5(10)-trien-17β-yl 3-cyclopentylpropanoate; estra-1,3,5(10)-triene-3,17β-diol 17-cyclopentanepropanoate; CAS Reg. No. 313-06-4.

Description. A white to almost white, crystalline powder.

Solubility. Soluble in alcohol, acetone and dioxane; sparingly soluble in vegetable oils; insoluble in water.

Category. Contraceptive.

Storage. Estradiol cipionate should be kept in tightly closed containers, protected from light.

Requirements

Definition. Estradiol cipionate contains not less than 97.0% and not more than 102.0% (“Assay”, method A) or not less than 98.0% and not more than 102.0% (“Assay”, method B) of C26H36O3, calculated with reference to the dried substance.

Identity tests

  • Either test A alone or tests B and C may be applied.

A. Carry out the examination as described under 1.7 Spectrophotometry in the infrared region. The infrared absorption spectrum is concordant with the spectrum obtained from estradiol cipionate RS or with the reference spectrum of estradiol cipionate.

B. Carry out the test as described under 1.14.1 Chromatography, High-performance liquid chromatography using the conditions given under “Assay”, method A. The retention time of the principal peak in the chromatogram obtained with solution (1) corresponds to the retention time of the peak due to estradiol cipionate in the chromatogram obtained with solution (2).

C. Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography using silica gel R6 as the coating substance and a mixture of ethanol (~750 g/L) TS and toluene R (20:80 V/V) as the mobile phase. Apply separately to the plate 10 µL of each of the following 3 solutions in methanol R containing (A) 1.0 mg of the test substance per mL, (B) 1.0 mg of estradiol cipionate RS per mL and (C) 1.0 mg of ethinylestradiol R and 1.0 mg estradiol hemihydrate R per mL. Develop the plate. After removing the plate from the chromatographic chamber allow it to dry in air or in a current of air. Spray the plate with sulfuric acid/ethanol (10%) TS and heat it to 105 °C for 10 minutes. Allow the plate to cool and examine the chromatogram in daylight and in ultraviolet light (365 nm). The principal spot in the chromatogram obtained with solution (A) corresponds in position, appearance and intensity with that obtained with solution (B). The test is not valid unless the chromatogram obtained with solution (C) shows two spots, which may however not be completely separated.

Specific optical rotation (1.4). Use a 20 mg/mL solution in dioxane R; = +39° to +44° with reference to the dried substance.

Loss on drying. Dry at 105 °C for 4 hours; it loses not more than 10 mg/g.

Sulfated ash (2.3). Not more than 1.0 mg/g.

Heavy metals (2.2.3). Use 1.0 g for the preparation of the test solution as described under 2.2.3 Limit test for heavy metals, Procedure 3; determine the heavy metals content according to Method A; not more than 10 μg/g.

Related substances. Carry out the test as described under 1.14.1 Chromatography, High-performance liquid chromatography, using the conditions given below under “Assay”, method A.

Prepare the following solutions in acetonitrile R. For solution (1) transfer about 50 mg of the test substance to a 50 mL volumetric flask and dilute to volume. For solution (2) dilute 1 volume of solution (1) to 1000 volumes. For solution (3) use a solution containing 0.5 mg of estradiol cipionate RS and 0.5 mg of estradiol cipionate impurity B RS per mL.

Inject 25 μL of solution (3). The test is not valid unless the resolution between the peak due to impurity B (with a relative retention of about 0.91) and the peak due to estradiol cipionate (retention time about 15 minutes) is at least 1.5.

Inject alternately 25 μL each of solution (1) and (2).

In the chromatogram obtained with solution (1) the following impurities, if present, are eluted at the following relative retention with reference to estradiol cipionate: impurity A about 0.17; impurity E about 0.76; impurity B about 0.91; impurity C about 1.44; and impurity D about 2.22.

In the chromatogram obtained with solution (1):

  • the area of any peak corresponding to impurity A, impurity C, impurity D or impurity E is not greater than 1.5 times the area of the principal peak in the chromatogram obtained with solution (2) (0.15 %);
  • the area of any peak corresponding to impurity B, when multiplied by a correction factor of 0.4 is not greater than 1.5 times the area of the principal peak in the chromatogram obtained with solution (2) (0.15 %);
  • the area of any other peak, other than the principal peak, is not greater than the area of the principal peak in the chromatogram obtained with solution (2) (0.10 %);
  • the sum of the area of any peak corresponding to impurity A, C, D and E, the corrected area of any peak corresponding to impurity B and the areas of all other peaks, other than the principal peak, is not greater than 10 times the area of the principal peak obtained with solution (2) (1.0%). Disregard any peak with an area less than 0.5 times the area of the principal peak in the chromatogram obtained with solution (2) (0.05%).

Assay

  • Either test A or test B may be applied.

A. Carry out the test as described under 1.14.1 Chromatography, High-performance liquid chromatography using a stainless steel column (25 cm x 4.6 mm) packed with base-deactivated particles of silica gel, the surface of which has been modified with chemically-bonded octadecylsilyl groups (5 µm).

Use the following conditions for gradient elution:

mobile phase A: Water R;

mobile phase B: Acetonitrile R.

Time

(min)

Mobile phase A

(% v/v)

Mobile phase B

(% v/v)

Comments

0–25

20

80

Isocratic

25–30

20 to 0

80 to 100

Linear gradient

30–40

0

100

Isocratic

40–41

0 to 20

100 to 80

Return to initial composition

41–50

20

80

Re-equilibration

Operate with a flow rate of 1.2 mL per minute. As a detector use an ultraviolet spectrophotometer set at a wavelength of 280 nm.

Prepare the following solutions in acetonitrile R. For solution (1) use 1.0 mg solution of the test substance per mL. For solution (2) use 1.0 mg of estradiol cipionate RS per mL. For solution (3) use a solution containing 0.5 mg of estradiol cipionate RS and 0.5 mg of estradiol cipionate impurity B RS per mL.

Inject 25 μL of solution (3). The test is not valid unless the resolution between the peak due to impurity B (with a relative retention of about 0.91) and the peak due to estradiol cipionate (retention time about 15 minutes) is at least 1.5.

Inject alternately 25 μL each of solution (1) and (2). Measure the areas of the peaks corresponding to estradiol cipionate obtained in the chromatograms, and calculate the percentage content of estradiol cipionate (C26H36O3), using the declared content of C26H36O3 in estradiol cipionate RS.

B. Dissolve about 0.05 g, accurately weighed, in sufficient methanol R to produce 100.0 mL; dilute 2.0 mL of this solution to 100.0 mL with the same solvent. Measure the absorbance (1.6) of a 1 cm layer of the diluted solution at the maximum at about 280 nm and calculate the percentage content of estradiol cipionate (C26H36O3) using the absorptivity value of estradiol cipionate.

[Note from the Secretariat. It is intended to determine the absorptivity value of estradiol cipionate during the establishment of estradiol cipionate RS. The value will then be included in the test description.]

Impurities

A. estra-1,3,5(10)-triene-3,17β-diol (estradiol)

B. 3-hydroxyestra-1,3,5(10),9(11)-tetraen-17β-yl 3-cyclopentylpropanoate (Δ9(11)-estradiol cipionate)

C. 3-hydroxy-4-methylestra-1,3,5(10)-trien-17β-yl 3-cyclopentylpropanoate (4-methylestradiol cipionate),

D. estra-1,3,5(10)-triene-3,17β-diyl bis(3-cyclopentylpropanoate) (estradiol dicipionate)

E. 3-hydroxyestra-1,3,5(10)-trien-17β-yl cyclopentylacetate (estradiol cyclopentylacetate)

to previous sectionto next section